• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Locoregional Therapy for Hepatocellular Carcinoma.

作者信息

Kudo M

出版信息

Liver Cancer. 2015 Sep;4(3):163-4. doi: 10.1159/000367741. Epub 2015 Jun 5.

DOI:10.1159/000367741
PMID:26674459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4608615/
Abstract
摘要

相似文献

1
Locoregional Therapy for Hepatocellular Carcinoma.肝细胞癌的局部区域治疗
Liver Cancer. 2015 Sep;4(3):163-4. doi: 10.1159/000367741. Epub 2015 Jun 5.
2
Locoregional therapy and recurrence of hepatocellular carcinoma after liver transplant.肝移植后肝细胞癌的局部区域治疗与复发
Exp Clin Transplant. 2014 Mar;12 Suppl 1:166-9.
3
Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis.术前局部区域治疗对肝细胞癌肝移植术后复发及患者生存的影响：一项荟萃分析
Scand J Gastroenterol. 2017 Feb;52(2):143-149. doi: 10.1080/00365521.2016.1236396. Epub 2016 Oct 3.
4
Battle Royale: Systemic Versus Locoregional Therapy for Unresectable Hepatocellular Carcinoma.《大逃杀：不可切除肝细胞癌的系统治疗与局部区域治疗》。
AJR Am J Roentgenol. 2018 Jun;210(6):1366-1367. doi: 10.2214/AJR.17.19392. Epub 2018 Apr 18.
5
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.钇-90微球放射性栓塞治疗不可切除的肝细胞癌
Cochrane Database Syst Rev. 2016 Feb 16;2:CD011313. doi: 10.1002/14651858.CD011313.pub2.
6
Locoregional Therapy for Hepatocellular Carcinoma with and without Extrahepatic Spread.伴有或不伴有肝外转移的肝细胞癌的局部区域治疗
J Vasc Interv Radiol. 2015 Aug;26(8):1112-21. doi: 10.1016/j.jvir.2015.04.006. Epub 2015 May 30.
7
Significance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantation.肿瘤坏死对于接受肝移植前局部区域治疗的肝细胞癌患者预后的意义。
Ann Surg Oncol. 2011 Sep;18(9):2638-46. doi: 10.1245/s10434-011-1779-z. Epub 2011 May 17.
8
Locoregional therapy-induced tumor necrosis as a predictor of recurrence after liver transplant in patients with hepatocellular carcinoma.局部区域治疗诱导的肿瘤坏死作为预测肝细胞癌患者肝移植后复发的指标。
Ann Surg Oncol. 2011 Dec;18(13):3632-9. doi: 10.1245/s10434-011-1803-3. Epub 2011 May 28.
9
Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.术前和术后辅助性局部区域靶向化疗联合局部区域靶向免疫刺激及手术切除治疗肝细胞癌。一种新的有前景的替代方案。
Anticancer Res. 1994 May-Jun;14(3B):1351-5.
10
Locoregional therapies for hepatocellular carcinoma: which patients are most likely to gain a survival advantage?局部区域治疗肝癌：哪些患者最有可能获得生存优势？
J Gastroenterol Hepatol. 2010 Jul;25(7):1299-305. doi: 10.1111/j.1440-1746.2010.06267.x.

引用本文的文献

1
Efficacy of Invariant Natural Killer T Cell Infusion Plus Transarterial Embolization vs Transarterial Embolization Alone for Hepatocellular Carcinoma Patients: A Phase 2 Randomized Clinical Trial.不变自然杀伤T细胞输注联合经动脉栓塞与单纯经动脉栓塞治疗肝细胞癌患者的疗效：一项2期随机临床试验
J Hepatocell Carcinoma. 2023 Aug 21;10:1379-1388. doi: 10.2147/JHC.S416933. eCollection 2023.
2
Extrahepatic Applications of Yttrium-90 Radioembolization.钇-90放射性栓塞术的肝外应用
Semin Intervent Radiol. 2021 Oct;38(4):479-481. doi: 10.1055/s-0041-1735573. Epub 2021 Oct 7.
3
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study.基线ALBI分级对接受乐伐替尼治疗的肝细胞癌患者预后的影响：一项多中心研究
Cancers (Basel). 2019 Jul 7;11(7):952. doi: 10.3390/cancers11070952.
4
Imaging performance and clinical value of contrast-enhanced ultrasonography and computed tomography in the diagnosis of liver cancer.超声造影与计算机断层扫描在肝癌诊断中的成像性能及临床价值
Oncol Lett. 2018 May;15(5):7669-7674. doi: 10.3892/ol.2018.8281. Epub 2018 Mar 15.
5
Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm.白蛋白-胆红素分级与肝细胞癌治疗算法
Liver Cancer. 2017 Jun;6(3):185-188. doi: 10.1159/000462199. Epub 2017 Mar 9.
6
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.瑞戈非尼和乐伐替尼开启肝细胞癌系统治疗新时代。
Liver Cancer. 2017 Jun;6(3):177-184. doi: 10.1159/000462153. Epub 2017 Mar 9.
7
Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update.肝细胞癌中的免疫检查点阻断：2017年更新
Liver Cancer. 2016 Nov;6(1):1-12. doi: 10.1159/000449342. Epub 2016 Nov 29.
8
Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma.瑞戈非尼作为二线全身治疗可能会改变肝细胞癌的治疗策略和管理模式。
Liver Cancer. 2016 Oct;5(4):235-244. doi: 10.1159/000449335. Epub 2016 Sep 14.
9
Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B.巴塞罗那临床肝癌B期的异质性与亚分类
Liver Cancer. 2016 Apr;5(2):91-6. doi: 10.1159/000367768. Epub 2016 Mar 17.
10
Breakthrough Imaging in Hepatocellular Carcinoma.肝细胞癌的突破性成像
Liver Cancer. 2016 Feb;5(1):47-54. doi: 10.1159/000367761. Epub 2015 Dec 18.

本文引用的文献

1
Surgical and Locoregional Therapy of HCC: TACE.肝癌的手术及局部区域治疗：经动脉化疗栓塞术
Liver Cancer. 2015 Sep;4(3):165-75. doi: 10.1159/000367739. Epub 2015 Jul 10.
2
Recent Advances in Tumor Ablation for Hepatocellular Carcinoma.肝细胞癌肿瘤消融的最新进展
Liver Cancer. 2015 Sep;4(3):176-87. doi: 10.1159/000367740. Epub 2015 Jul 17.
3
Current Status of Hepatic Arterial Infusion Chemotherapy.肝动脉灌注化疗的现状
Liver Cancer. 2015 Sep;4(3):188-99. doi: 10.1159/000367746. Epub 2015 Aug 12.
4
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.《日本肝癌研究组基于JSH共识的肝细胞癌管理临床实践指南：2014年更新》
Liver Cancer. 2014 Oct;3(3-4):458-68. doi: 10.1159/000343875.
5
Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe.日本、美国和欧洲之间肝细胞癌的临床实践指南存在差异。
Liver Cancer. 2015 Mar;4(2):85-95. doi: 10.1159/000367730.
6
Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation.早期计算机断层扫描所确定的消融边缘不足可能预示着肝细胞癌射频消融术后的复发。
Liver Cancer. 2015 Mar;4(1):26-38. doi: 10.1159/000343877.
7
Radiotherapeutic options for hepatocellular carcinoma with portal vein tumor thrombosis.伴有门静脉癌栓的肝细胞癌的放射治疗选择
Liver Cancer. 2014 Mar;3(1):18-30. doi: 10.1159/000343855.
8
Local ablation for hepatocellular carcinoma in taiwan.台湾地区肝细胞癌的局部消融治疗
Liver Cancer. 2013 Apr;2(2):73-83. doi: 10.1159/000343843.
9
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.日本肝细胞癌的管理：日本肝脏学会（JSH）2010 年更新版提出的基于共识的临床实践指南。
Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9.
10
Management of hepatocellular carcinoma: an update.肝细胞癌的管理：最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.